Appyea Inc (APYP) 0.0011 $APYP AppYea Falls Victim to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Appyea Inc (APYP) 0.0011 $APYP

AppYea Falls Victim to Elaborate Fraud
Marketwired - Thu Apr 28, 5:06PM CDT
APPYEA Inc. (OTCQB: APYP), a fully reporting company, announced today that the Company has fallen victim to an elaborate fraud. On April 19, 2016, an as yet unidentified party issued a fraudulent press release claiming that AppYea had entered into a Letter of Intent ("LOI" to purchase all the outstanding stock of a mobile application development company. The Company has not entered into any such LOI.

AppYea Announces LOI to Acquire Intellectsoft Through Stock Purchase Agreement
Marketwired - Tue Apr 19, 8:15AM CDT
AppYea Inc (OTCQB: APYP) is pleased to announce a letter of intent to acquire Intellectsoft, a leading developer and manufacturer of software applications with a major global footprint. AppYea has come to an understanding to purchase all the outstanding of stock of Intellectsoft, in a deal that will enhance the company's financial standing by adding millions of dollars in annual revenue.

AppYea Acquires 60 iOS Apps Through Asset Purchase Agreement
GlobeNewswire - Thu Dec 10, 7:00AM CST
APPYEA (OTCQB:APYP) is pleased to announce the recent acquisition of 60 mobile applications through an asset purchase agreement. This new acquisition adds to the company's current diversified app holdings portfolio. The primary focus for this portfolio of apps is in the gaming apps arena.

Scanning Stocks from Diverse Sectors - Research on Kimberly Parry Organics, APPYEA, Kirin International Holding, and Black Stallion Oil & Ga
ACCESSWIRE - Mon Nov 02, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Kimberly Parry Organics Inc. (OTC: KPOC), APPYEA INC (OTC: APYP), Kirin International Holding, Inc. (OTC: KIRI) and Black Stallion Oil & Gas (OTC: BLKG). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.

Apple Approves 17 of AppYea's New Gaming Apps for Apples' iOS Platform
GlobeNewswire - Fri Oct 09, 4:15PM CDT
APPYEA (OTCQB:APYP) is pleased to announce that Apple has approved all 17 of their new gaming apps which will be added to their gaming portfolio. AppYea's new apps consist of 10 apps for the new iWatch which includes Simon Says, 8 Puzzle, Quick Quiz and Tic Tac Toe just to name a few and 7 for the iPhone which includes Hearts Match, Bug Smash, Doodle Birdy and 777 Slots.

AppYea is Ready to Launch Suite of Gaming Apps for Apples' iOS Platform
GlobeNewswire - Fri Aug 28, 11:01AM CDT
APPYEA (OTCQB:APYP) announces its formal plans to launch a series of 16 new games to its gaming portfolio, 9 of which that will be for the new iWatch and 7 for the iOS platform. The company plans to launch each of the 16 apps as they're finished and sent to Apple for approval.

AppYea, Inc. Develops New Mobile Application for Apple Watch
GlobeNewswire - Tue Aug 11, 8:00AM CDT
APPYEA, Inc. (OTCQB:APYP) - AppYea's development team is configuring the Company's current Universal Studio/Disney World wait time apps to be compatible with the Apple WatchOS 2, scheduled to launch this fall. AppYea's management plans an aggressive marketing campaign to coincide with Apple's launch. The Company currently offers 7 different Disney World/Universal Studio theme park wait time apps in 5 different languages on both the Apple App Store and Google Play.

AppYea Targets Gaming Asset Portfolios as Company Submits Letters of Intent
GlobeNewswire - Mon Jul 13, 8:00AM CDT
APPYEA, Inc. (OTCQB:APYP) - AppYea wishes to provide shareholders with an update regarding their Mobile Application Mergers & Acquisition Strategic Alliance Growth Plan aimed at broadening its base of mobile applications. Utilizing its team of experienced business brokers specializing in the mobile application space, AppYea has submitted offers for the acquisition of two mobile application portfolios to add to their growing holdings. Additional information will be released when finalized.

AppYea Hits 1 Million Downloads With Its Disney World/Universal Studio Wait Time App Portfolio
GlobeNewswire - Thu Jun 04, 8:00AM CDT
AppYea Inc. (OTCQB:APYP) is pleased to announce that they have surpassed 1 million downloads with its Disney World/Universal Studio wait time app portfolio. They have also begun expanding development of their portfolio which will be aimed at further engagement with social sharing. These upgrades will include video integration via Facebook, YouTube, Vimeo, and Vine and it will also include photo sharing via Instagram, Facebook and Twitter. These upgrades will also include updating to iOS 8.2.

Joe Abrams' Cicero Consulting Group Joins AppYea
GlobeNewswire - Tue Mar 24, 8:30AM CDT
AppYea Inc (OTCQB:APYP) is pleased to announce that it has signed a consulting agreement with Cicero Consulting Group, LLC. Cicero will assist AppYea management with strategic growth including identifying and negotiating with potential merger and acquisition candidates and evaluating potential public market opportunities. They will also advise management on any additional operational or strategic decisions as needed.
PSO: 11.70 (-0.04)

APPYEA Launches 2015 Mobile Application M & A Strategic Alliance Growth Plan
GlobeNewswire - Mon Feb 16, 8:30AM CST
APPYEA Inc (OTCQB:APYP) the Company, lead by CEO Jackie D. Williams Jr, a team of highly experienced business brokers and several strategic M & A financiers are kicking off its M & A Strategic Alliance Growth Plan which will be aimed to broaden its base of mobile applications. The Company is aggressively seeking strong opportunities, both in the U.S. and internationally, in the $17 Billion Mobile App Gaming Market.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 342

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 182

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

HALiXPEDITE Revolutionizes Biologics Therapy Development Process

Updated Category News Views 147

HALiXPEDITE: Transforming the Future of Biologics Development HALIX, a prominent global healthcare Contract Development and Manufacturing Organization (CDMO), recently unveiled its innovative platform, HALiXPEDITE, at a notable conference. This platform is specifically designed to expedite the development of biologics therapies, focusing on a streamlined approach to...

Continue Reading
Day One Biopharmaceuticals to Share Q3 2025 Insights

Updated Category News Views 170

Day One Biopharmaceuticals to Present Q3 2025 Financial Results In a busy season for the biopharmaceutical industry, Day One Biopharmaceuticals (Nasdaq: DAWN) has announced it will host a live conference call and webcast aimed at reporting its financial results and outlining corporate progress for the third quarter of 2025. Conference Call Details The event is scheduled...

Continue Reading
Leica Biosystems Promotes DICOM Standards for Digital Pathology

Updated Category News Views 114

Leica Biosystems Promotes DICOM Standards for Digital Pathology Leica Biosystems, a prominent figure in anatomic pathology, has recently made waves in the medical field with a bold new initiative. By announcing the non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, they aim to boost the implementation of...

Continue Reading
LYNPARZA: A Breakthrough in Early Breast Cancer Treatments

Updated Category News Views 288

Significant Survival Benefits with LYNPARZA in Breast Cancer Recent findings from the OlympiA Phase III trial bring exciting news for patients battling early breast cancer. AstraZeneca and Merck & Co., Inc.'s LYNPARZA (olaparib) has showcased profound improvements in survival rates among patients with germline BRCA-mutated HER2-negative high-risk early breast cancer. This...

Continue Reading
EuroDry Limited's Stock Experiences Volatility Amid Challenges

Updated Category News Views 229

EuroDry Limited Faces Stock Turmoil EuroDry Ltd. (NASDAQ: EDRY), a leading provider in drybulk shipping, has recently encountered a tumultuous phase, with its stock reaching a noteworthy low at $14.1. This decline marks a significant reflection on the year's challenges the company has faced, indicated by a -14.71% change over the past year. Market Conditions and...

Continue Reading